Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1250
http://purl.obolibrary.org/obo/NCIT_C1250
|
|---|---|
| Preferred Name | Ormaplatin |
| Definitions |
A platinum(IV) analogue with antineoplastic activity. Ormaplatin alkylates DNA, forming both inter- and intra-strand platinum-DNA crosslinks, which result in inhibition of DNA replication and transcription and cell-cycle nonspecific cytotoxicity.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A platinum(IV) analogue with antineoplastic activity. Ormaplatin alkylates DNA, forming both inter- and intra-strand platinum-DNA crosslinks, which result in inhibition of DNA replication and transcription and cell-cycle nonspecific cytotoxicity. |
|---|---|
| label | Ormaplatin
|
| prefLabel | Ormaplatin
|
| Legacy Concept Name | Ormaplatin
|
| in_subset | |
| Preferred_Name | Ormaplatin
|
| Is_Value_For_GDC_Property | |
| Chemical_Formula | C6H14N2.4Cl.Pt
|
| Maps_To | Ormaplatin
|
| PDQ_Open_Trial_Search_ID | 41211
|
| UMLS_CUI | C0076329
|
| FDA_UNII_Code | SFK1SGY8V1
|
| prefixIRI | NCIT:C1250
|
| NCI_Drug_Dictionary_ID | 41211
|
| Contributing_Source | FDA
|
| subClassOf | |
| code | C1250
|
| type | |
| NSC Number | 363812
|
| PDQ_Closed_Trial_Search_ID | 41211
|
| Semantic_Type |
Pharmacologic Substance
Inorganic Chemical
|
| CAS_Registry | 62816-98-2
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |